These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28572801)

  • 1. Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients.
    Khaibullin T; Ivanova V; Martynova E; Cherepnev G; Khabirov F; Granatov E; Rizvanov A; Khaiboullina S
    Front Immunol; 2017; 8():531. PubMed ID: 28572801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
    Khaiboullina SF; Gumerova AR; Khafizova IF; Martynova EV; Lombardi VC; Bellusci S; Rizvanov AA
    Biomed Res Int; 2015; 2015():189638. PubMed ID: 26295034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis.
    Franciotta D; Zardini E; Ravaglia S; Piccolo G; Andreoni L; Bergamaschi R; Romani A; Tavazzi E; Naldi P; Ceroni M; Marchioni E
    J Neurol Sci; 2006 Sep; 247(2):202-7. PubMed ID: 16784758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay.
    Pranzatelli MR; Tate ED; McGee NR; Colliver JA
    J Interferon Cytokine Res; 2013 Sep; 33(9):523-8. PubMed ID: 23659672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease.
    Niino M; Ogata A; Kikuchi S; Tashiro K; Nishihira J
    J Neurol Sci; 2000 Oct; 179(S 1-2):127-31. PubMed ID: 11054496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
    Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Skin-Brain Connection Hypothesis, Bringing Together CCL27-Mediated T-Cell Activation in the Skin and Neural Cell Damage in the Adult Brain.
    Blatt NL; Khaiboullin TI; Lombardi VC; Rizvanov AA; Khaiboullina SF
    Front Immunol; 2016; 7():683. PubMed ID: 28138328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
    Szczuciński A; Losy J
    Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis.
    Saruhan-Direskeneli G; Gürses C; Demirbilek V; Yentür SP; Yilmaz G; Onal E; Yapici Z; Yalçinkaya C; Cokar O; Akman-Demir G; Gökyiğit A
    Cytokine; 2005 Oct; 32(2):104-10. PubMed ID: 16226466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
    Mellergård J; Edström M; Vrethem M; Ernerudh J; Dahle C
    Mult Scler; 2010 Feb; 16(2):208-17. PubMed ID: 20007431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
    Cristofanilli M; Rosenthal H; Cymring B; Gratch D; Pagano B; Xie B; Sadiq SA
    Exp Neurol; 2014 Nov; 261():620-32. PubMed ID: 25111532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis.
    Martynova E; Goyal M; Johri S; Kumar V; Khaibullin T; Rizvanov AA; Verma S; Khaiboullina SF; Baranwal M
    Mediators Inflamm; 2020; 2020():2727042. PubMed ID: 33162830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
    Nakajima H; Fukuda K; Doi Y; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
    Eur Neurol; 2004; 52(3):162-8. PubMed ID: 15528917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention.
    Burman J; Svensson E; Fransson M; Loskog AS; Zetterberg H; Raininko R; Svenningsson A; Fagius J; Mangsbo SM
    J Neuroimmunol; 2014 Dec; 277(1-2):153-9. PubMed ID: 25457841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.